Resuming antiplatelet therapy in patients with intracranial hemorrhage

Asmaa Ahmed; Mohamed Hamed; Mona Mahmoud; Mamas A Mamas; Ayman Elbadawi; APICH

doi:10.1016/j.ejim.2024.02.029

Resuming antiplatelet therapy in patients with intracranial hemorrhage

Eur J Intern Med. 2024 Jul:125:135-136. doi: 10.1016/j.ejim.2024.02.029. Epub 2024 Mar 26.

Authors

Asmaa Ahmed¹, Mohamed Hamed², Mona Mahmoud³, Mamas A Mamas⁴, Ayman Elbadawi⁵; APICH

Collaborators

APICH:
Ahmed Elkheshen⁶, Arthur Weiner², Wissam Khalife⁷, Amr Mohsen⁸, Hani Jneid⁷

Affiliations

¹ Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA.
² Division of Cardiology, Florida Atlantic University, Boca Raton, FL, USA.
³ Division of Cardiology, University of Toledo, Toledo, OH, USA.
⁴ Keele Cardiovascular Research Group, Keele University, Keele, UK.
⁵ Division of Cardiology, Christus Good Shepherd Medical Center, Longview, TX, USA; Texas A&M School of Medicine, Christus Good Shepherd Medical Center, Longview, TX., USA. Electronic address: [email protected].
⁶ Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
⁷ Division of Cardiology, University of Texas Medical Branch, Galveston, TX, USA.
⁸ Division of Cardiology, Loma Linda University, Loma Linda, CA, USA.

PMID: 38538417
DOI: 10.1016/j.ejim.2024.02.029

No abstract available

Keywords: Antiplatelets; Antithrombotics; ICH; Intracranial hemorrhage; Ischemic stroke; Ischemic vascular events; Recurrent intracranial hemorrhage.

Publication types

Letter

MeSH terms

Humans
Intracranial Hemorrhages* / chemically induced
Male
Platelet Aggregation Inhibitors* / administration & dosage
Platelet Aggregation Inhibitors* / adverse effects
Platelet Aggregation Inhibitors* / therapeutic use

Substances

Platelet Aggregation Inhibitors